- Founded
- 2017
- Employees
- 175
- Total Funding
- $104.2M
Founded by Darrell Irvine, Jacob Becraft, Ron Weiss, Tasuku Kitada in 2017.
About Strand Therapeutics
Strand Therapeutics is a clinical-stage biotechnology company pioneering programmable mRNA therapeutics to unlock the full potential of genetic medicines. Strand is applying its proprietary Signal Stack platform, which integrates EverScript circular RNA, AmpliScript self-replicating RNA, SignalPath targeted delivery, and logic-driven SignalLock genetic circuits to enable precise control of therapeutic activity across tissues and cell types and overcome foundational limitations in targeting, durability, and safety. Strand is advancing a pipeline with an initial focus on oncology and autoimmune disease. Its initial program, STX-001, an intratumorally delivered LNP-encapsulated...
Leadership at Strand Therapeutics
The team at the top of the org chart.
Jake Becraft
Co-Founder and CEO
72 reports
Tasuku Kitada
President, Head of R&D & Co-Founder
52 reports
Samta Kundu
Chief Operating Officer
10 reports
Colleen Wilson
Chief People Officer
2 reports
Jason Luke
Chief Medical Officer
Michael Bertram
Vp, Finance & Controller
2 reports
Melissa Lucas
Manager of Business Operations
Board
Darrell J. Irvine
Scientific Co-Founder
Ron Weiss
Co-founder
K. Dane Wittrup
Scientific Advisor
Mark W. Frohlich
Clinical Advisor
Stuart Chaffee
Independent Board Advisor
Jory Bell
Board Member
Open Jobs at Strand Therapeutics (3)
Similar companies hiring
Top employers in Biotechnology